雷诺现象:关于病变发生,诊断工作和治疗的最新情况
Hirut Yadeta Ture1, Nan Young Lee2, Na Ri Kim1
1Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
雷诺现象 (RP) 涉及到四肢的偶发性血管收缩. 管理策略包括药物,如通道阻断剂和先进疗法,如肉毒素注射和重症病例的脂肪移植.
科学领域:
- 血管医学 血管医学
- 类风湿病学 类风湿病学
- 皮肤病学 皮肤病学
背景情况:
- 雷诺氏现象 (RP) 是一种影响数字的血管动性疾病,由寒冷或压力引发.
- 它呈现出特征性的颜色变化:白 (血管收缩),蓝色 (脱氧化) 和红血 (再).
- 脊髓炎可能是原发性 (异常性) 或继发性自身免疫性疾病 (如系统性硬化症),血管或神经疾病.
研究的目的:
- 提供雷诺现象的全面概述.
- 讨论潜在的病理生理学,诊断方法和当前的管理策略.
- 突出治疗干预的最新进展.
主要方法:
- 基于特征性症状和体检的临床诊断.
- 爪毛细分镜作为区分初级和二级RP的黄金标准.
- 血管成像用于评估缺血损伤和指导术前决策.
主要成果:
- 病变发生涉及影响血管度的复杂相互作用,在初级RP中存在功能异常,在二级RP中存在功能和结构异常.
- 二次性RP与数字组织损伤的风险更高有关.
- 爪毛细膜镜对于差异诊断至关重要.
结论:
- 有效的RP管理需要缓解症状和预防组织损伤.
- 第一线治疗包括生活方式的改变和血管扩张药物,如通道阻塞剂.
- 先进的疗法,如内甲素受体抗剂,毒素,同情切除术和脂肪移植,为耐火或严重的病例提供了选择.
更多相关视频
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
10:50Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
相关概念视频
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
